RNXT · Healthcare · $71M
$1.57+1.29%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
6/'26
3/'26 vs prev quarter
Among 326 Biotechnology peers
Quarterly Revenue Growth
“매출이 90만9천 달러로 전 분기 56만3천 달러보다 61% 뛰며, 25년 4분기 23만8천 달러 이후 두 분기 연속 가속됐어요.”
In the company's words · 2026 2분기 earnings call